LifeStance Health Group (LFST) Projected to Post Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST - Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, February 27th. Analysts expect LifeStance Health Group to post earnings of ($0.04) per share and revenue of $313.96 million for the quarter. Investors interested in listening to the company's conference call can do so using this link.

LifeStance Health Group Stock Performance

NASDAQ LFST traded down $0.28 on Friday, hitting $7.62. 563,594 shares of the company traded hands, compared to its average volume of 931,450. The company has a market capitalization of $2.91 billion, a price-to-earnings ratio of -29.29 and a beta of 1.28. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The business's 50 day moving average price is $7.76 and its 200-day moving average price is $7.14. LifeStance Health Group has a 52-week low of $4.64 and a 52-week high of $9.20.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of LifeStance Health Group stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the transaction, the director now owns 1,424,447 shares of the company's stock, valued at approximately $10,740,330.38. The trade was a 5.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 6.60% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on LFST shares. Barclays upped their target price on LifeStance Health Group from $6.00 to $7.00 and gave the company an "underweight" rating in a research report on Monday, November 11th. The Goldman Sachs Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective on the stock in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $8.70.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.